Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT

Fig. 2

Confirmed miRNA expression by quantitative real-time PCR. a Amplification plots of miRNA-22; b Disassociation curves of miRNA-22; c Amplification plots of miRNA-26b; d Disassociation curves of miRNA-26b; E, Before NPC patients treated with CCRT, miRNA-22 and miRNA-26b were down-regulated in serum from EG versus CG; f After treated with CCRT, miRNA-22 and miRNA-26b were down-regulated in serum from EG versus CG. The experiment was conducted in triplicate and the relative expression level of each miRNA was normalized to RNU6B. The result is consistent with the microarrays. * P < 0.05 versus CG group

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us